The lord of the ring: mandatory role of the kidney in drug therapy of hypertension.

作者: Francisco J. López-Hernández , José M. López-Novoa

DOI: 10.1016/J.PHARMTHERA.2005.08.002

关键词:

摘要: Strong evidence supports the idea that total peripheral resistance (TPR) is increased in all forms of human and experimental hypertension. Although etiological participation TPR origin long-term maintenance hypertension has been extensively debated, it now seems clear renal, nonadaptive, infinite gain-working, pressure-sensitive natriuresis diuresis main mechanism blood pressure control long term. The tissue, cellular, biochemical, genetic sensors executors this process have not fully identified yet, but role renal medulla gained growing attention as physiopathological scenario which key regulatory elements reside. Specifically, functionality renomedullary vasculature to be highly responsible for control. becomes a new more specific target therapeutic intervention Recent data on effect baroreceptor-controlled sympathetic activity regulation are integrated. effects antihypertensive drugs discussed, perspectives outlined. Comparison program before after development spontaneously hypertensive experimentally induced animal models might provide identifying genes become activated or suppressed high pressure. These genes, their encoded proteins, other related signalling pathways serve targets pharmacological treatment abnormally elevated Besides, proteins specifically located luminal side vascular endothelium may potential site-directed drug gene therapy.

参考文章(356)
Julio A. Panza, Endothelial dysfunction in essential hypertension Clinical Cardiology. ,vol. 20, ,(1997) , 10.1002/J.1932-8737.1997.TB00009.X
E. Eric Muirhead, The medullipin system of blood pressure control. American Journal of Hypertension. ,vol. 4, pp. 556- 568 ,(1991) , 10.1093/AJH/4.10.556S
Francisco J. López-Hernández, María J. Montero, Rosalía Carrón, Mesenteric cyclooxygenase products after combined antihypertensive treatment in uninephrectomized SHRs. Cardiovascular Drugs and Therapy. ,vol. 14, pp. 41- 48 ,(2000) , 10.1023/A:1007839104402
Y. C. Fung, Physical Principles of Circulation Springer, New York, NY. pp. 1- 22 ,(1997) , 10.1007/978-1-4757-2696-1_1
Vicaut E, Microcirculation and arterial hypertension. Drugs. ,vol. 58, pp. 1- 10 ,(1999)
Kathleen P. O’Hagan, Gail D. Thomas, Edward J. Zambraski, Renal denervation decreases blood pressure in DOCA-treated miniature swine with established hypertension. American Journal of Hypertension. ,vol. 3, pp. 62- 64 ,(1990) , 10.1093/AJH/3.1.62
Guyton Ac, Young Db, Hall Je, DeClue Jw, Trippodo N, Fluid balance, renal function, and blood pressure. Clinical Nephrology. ,vol. 4, pp. 122- ,(1975)
Y. M. Chen, N. H. Holstein-Rathlou, Differences in dynamic autoregulation of renal blood flow between SHR and WKY rats American Journal of Physiology-renal Physiology. ,vol. 264, ,(1993) , 10.1152/AJPRENAL.1993.264.1.F166
P.A. van Zwieten, Centrally Acting Imidazoline I1-Receptor Agonists American Journal of Cardiovascular Drugs. ,vol. 1, pp. 321- 326 ,(2001) , 10.2165/00129784-200101050-00002